Interview with Erika Koppers, COO & GM, Roche SA
You have worked at Roche for several years as Business unit Manager. Therefore you are familiar with the strategy of the company and the intricacies of the job. The new…
Address: Glenhove Square Building 3 71-4 th Street Houghton Estate 2198 South Africa
Tel: -479
Web: http://www.keyoncologics.co.za/
Key Oncologics (Pty) Ltd is a South African biopharmaceutical company that primarily focuses on the treatment of cancer and allied diseases. We represent international companies that do not have offices in South Africa. Our aim is to have a comprehensive range of generic and proprietary oncology products in our portfolio.
Key Oncologics (Pty) Ltd has experience in registering, marketing, selling and distributing cancer products in the South African market.
Key Oncologics (Pty) Ltd has a clinical trial division with the necessary infrastructure to conduct Oncology Clinical Trials according to GCP.
Key Oncologics is recognised for its comprehensive oncology portfolio, including both proprietary and generic products.
You have worked at Roche for several years as Business unit Manager. Therefore you are familiar with the strategy of the company and the intricacies of the job. The new…
Having spent two months as the head of Novartis South Africa, what is your first assignment as General Manager, could you share with our readers what were the surprises for…
Mr. Miller, you have been Vice President and Managing Director of Mylan’s operations in South Africa since 2008. What mission were you assigned back then, and in those three years,…
South Africa carries one of the world’s most disproportionate disease burdens, the worst of so-called westernised diseases, such as cardiac disease, diabetes etc on the one hand and the developmental…
Mr Norman, could you tell us a few words on the transformation process that the company is currently going through? Takeda acquired Nycomed in October 2011, because it was an…
If we take a look at MSD’s international presence, the group has grown into the third largest pharma company in the world. Here in South Africa, you are in the…
Focus Reports is back in South Africa as part of a second set of reports on the BRICS. What would you say are the main changes in the market since…
South Africa is at the moment one of the world’s most exciting and dynamic markets at the moment as Mr. Omar Ehsan was telling us, the most exciting market he…
Could you introduce to our readers MC Pharma’s business model in the South African market as well as the main milestones in the company’s development over the recent years? MC…
Mr. Daniel, after working with Pfizer Australia, working in Hong Kong as Regional Marketing Director for the Asian operation and in Japan, you have been the first South African appointed…
South Africa has recently achieved the 1st Millennium Development Goal (MDG) – reducing the proportion of the population living on less than 1 USD a day by half – but…
Your professional career went back and forth between creating your own business and running a smaller and very dynamic structure and managing over a thousand of employees for multinational organizations.…
See our Cookie Privacy Policy Here
